Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Bsteh

Showing results (71-80 of 169) with videos related to

Pageof 17
Sort By:
Frontiers in Neurology|July 22, 2022
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple SclerosisNik Krajnc, Gabriel Bsteh, Gregor Kasprian, et al.
Multiple Sclerosis and Related Disorders|April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre studyFranziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis and Related Disorders|August 2, 2020
Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 27, 2015
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseasesMelanie Ramberger, Gabriel Bsteh, Kathrin Schanda, et al.
Plos One|August 5, 2017
Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective studySebastian Wurth, Bettina Kuenz, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|May 22, 2018
Transient impairment of olfactory threshold in acute multiple sclerosis relapseGabriel Bsteh, Harald Hegen, Felix Ladstätter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2023
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 3, 2017
Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosisGabriel Bsteh, Harald Hegen, Barbara Teuchner, et al.
Digital Health|November 10, 2022
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trialPatrick Altmann, Markus Ponleitner, Tobias Monschein, et al.
Pageof 17

Showing results (71-80 of 169) with videos related to

Sort By:
Pageof 17
Frontiers in Neurology|July 22, 2022
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple SclerosisNik Krajnc, Gabriel Bsteh, Gregor Kasprian, et al.
Multiple Sclerosis and Related Disorders|April 27, 2022
Alemtuzumab induced hemodynamic change in relapsing multiple sclerosis occurs independent of corticosteroid premedication - a retrospective multicentre studyFranziska Di Pauli, Katharina Riedl, Harald Hegen, et al.
Multiple Sclerosis and Related Disorders|August 2, 2020
Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Multiple Sclerosis and Related Disorders|March 13, 2024
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 27, 2015
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseasesMelanie Ramberger, Gabriel Bsteh, Kathrin Schanda, et al.
Plos One|August 5, 2017
Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective studySebastian Wurth, Bettina Kuenz, Gabriel Bsteh, et al.
Multiple Sclerosis and Related Disorders|May 22, 2018
Transient impairment of olfactory threshold in acute multiple sclerosis relapseGabriel Bsteh, Harald Hegen, Felix Ladstätter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2023
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosisKlaus Berek, Harald Hegen, Michael Auer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 3, 2017
Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosisGabriel Bsteh, Harald Hegen, Barbara Teuchner, et al.
Digital Health|November 10, 2022
Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trialPatrick Altmann, Markus Ponleitner, Tobias Monschein, et al.
Pageof 17